Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Ginkgo Bioworks Holdings, Inc. Class A Common Stock
(NY:
DNA
)
5.700
-0.260 (-4.36%)
Official Closing Price
Updated: 7:00 PM EDT, Apr 3, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Ginkgo Bioworks Holdings, Inc. Class A Common Stock
< Previous
1
2
...
10
11
12
13
14
15
16
17
Next >
Tesla Bull Cathie Wood Scoops Up $11.5M In Bill Gates-Backed Biotech's Stock
May 19, 2022
Ark Investment Management, led by Tesla Inc.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 18, 2022
May 18, 2022
Via
Benzinga
BofA Downgrades Ginkgo Bioworks, Cuts Price Target In Half
May 18, 2022
While Ginkgo Bioworks Holdings Inc’s (NYSE: DNA) overall first-quarter results were better than expected, revenues and active programs in its core Foundry segment fell short of estimates, according to...
Via
Benzinga
Why Ginkgo Bioworks Stock Is Falling After Hours
May 16, 2022
Ginkgo Bioworks Holdings Inc (NYSE: DNA) shares are trading lower in Monday's after-hours session after the company
Via
Benzinga
Earnings Scheduled For May 16, 2022
May 16, 2022
Companies Reporting Before The Bell • AcelRx Pharmaceuticals (NASDAQ:ACRX) is estimated to report quarterly loss at $0.06 per share on revenue of $550.00 thousand.
Via
Benzinga
Why Is Ginkgo Bioworks (DNA) Stock Up Today?
April 13, 2022
Biotechnology company Ginkgo Bioworks has a host of promising collaboration announcements. DNA stock is up as a result.
Via
InvestorPlace
Ginkgo Bioworks Shares Gain As Q4 Sales, FY22 Guidance Surpass Street Expectations
March 29, 2022
Ginkgo Bioworks Holdings Inc (NYSE: DNA) reported
Via
Benzinga
Mid-Afternoon Market Update: Crude Oil Down Over 1%; Jumia Technologies Shares Spike Higher
May 17, 2022
U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining around 200 points on Tuesday.
Via
Benzinga
Looking Into Ginkgo Bioworks Holdings's Recent Short Interest
May 13, 2022
Ginkgo Bioworks Holdings's (NYSE:DNA) short percent of float has risen 9.65% since its last report. The company recently reported that it has 81.30 million shares sold short,...
Via
Benzinga
7 Growth Stocks to Buy on the Dip
May 10, 2022
Although the wave of red ink in the major indices is intimidating, it also presents an intriguing opportunity for growth stocks to buy.
Via
InvestorPlace
Cathie Wood Keeps Buying Gingko Bioworks (DNA) Stock. Here’s Why.
April 27, 2022
DNA stock is in the spotlight after Ark Invest reported purchasing more than 1.5 million shares this week. So, who else is betting big on Ginkgo?
Via
InvestorPlace
7 Biggest Loser Stocks That Could Become Surprising Buys
April 27, 2022
A huge pouring of red ink can sometimes lead to extraordinary gains, though you’ve got to be aware of the risks.
Via
InvestorPlace
Why BofA Sees 'Better Entry Point' In Ginkgo Bioworks Stock
January 28, 2022
Ginkgo Bioworks Holdings Inc (NYSE: DNA) is “at the forefront of the rising SynBio wave, a market we think holds much long-term promise,” according to BofA Securities.
Via
Benzinga
28 Biggest Movers From Yesterday
April 14, 2022
Gainers HighPeak Energy, Inc. (NASDAQ: HPK) shares gained 31.76% to close at $28.83 on Wednesday, after CNBC’s Jim Cramer said the mid-cap company is an aggressive play on...
Via
Benzinga
NYSE:DNA Long Term Investor Alert: Investigation of Potential Wrongdoing at Ginkgo Bioworks Holdings, Inc.
April 13, 2022
San Diego, CA -- (SBWIRE) -- 04/13/2022 -- An investigation was announced concerning potential breaches of fiduciary duties by certain directors of Ginkgo Bioworks Holdings, Inc.
Via
SBWire
Elanco, Ginkgo Bioworks Launch BiomEdit, Microbiome-Focused Animal Health Firm
April 11, 2022
Elanco Animal Health Incorporated (NYSE: ELAN) and Ginkgo Bioworks Holdings Inc (NYSE: DNA) have launched BiomEdit, a microbiome innovation company....
Via
Benzinga
Baillie Gifford Just Bought Ginkgo Bioworks (DNA) Stock. Here’s Why.
April 07, 2022
Baillie Gifford recently disclosed that it purchased 48.8 million shares of DNA stock on March 31. The firm has a $180 billion portfolio.
Via
InvestorPlace
Twist Bioscience and Ginkgo Bioworks Sign New Collaboration
April 05, 2022
From
Twist Bioscience Corporation
Via
Business Wire
36 Stocks Moving In Tuesday's Mid-Day Session
March 29, 2022
Gainers China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) jumped 88.1% to $0.38 after declining 9% on Monday. McCormick (NASDAQ: IGMS) shares jumped 49.8% to $22.46. Sanofi SA (...
Via
Benzinga
53 Biggest Movers From Yesterday
March 30, 2022
Gainers IGM Biosciences, Inc. (NASDAQ: IGMS) shares gained 96.7% to settle at $29.49 on Tuesday. Sanofi SA (NASDAQ: SNY) and IGM Biosciences signed an exclusive worldwide...
Via
Benzinga
Here's Why Ginkgo Bioworks Shares Are Rising
March 29, 2022
Ginkgo Bioworks Holdings Inc (NYSE: DNA) shares are trading higher by 22.0% at $4.56 after the company reported better-than-expected fourth-quarter sales results and issued FY22 sales guidance above...
Via
Benzinga
Is DNA Stock a Buy After Earnings? 3 Analysts Weigh In on Gingko Bioworks.
March 29, 2022
DNA stock is bouncing higher following a better-than-expected earnings report and strong forward guidance from Gingko Bioworks.
Via
InvestorPlace
8 Materials Stocks Moving In Tuesday's Pre-Market Session
March 29, 2022
Gainers Ginkgo Bioworks Holdings (NYSE:DNA) shares rose 9.9% to $4.11 during Tuesday's pre-market session. The market value of their outstanding shares is at $6.8 billion. The company's, Q4 earnings...
Via
Benzinga
Why Ginkgo Bioworks Stock Is Rising After Hours
March 28, 2022
Ginkgo Bioworks Holdings Inc (NYSE: DNA) is trading higher in Monday's after-hours session after the company reported financial results and issued guidance above estimates.
Via
Benzinga
Earnings Scheduled For March 28, 2022
March 28, 2022
Companies Reporting Before The Bell • LGL Group (AMEX:LGL) is likely to report quarterly earnings at $0.10 per share on revenue of $7.20 million.
Via
Benzinga
Ginkgo Bioworks Adds Ultra-High-Throughput Screening Platform Via FGen Acquisition
March 14, 2022
Ginkgo Bioworks Holdings Inc (NYSE: DNA) has agreed to acquire FGen AG, a Swiss company specializing in strain development and optimization. Under the...
Via
Benzinga
23 Stocks That Have Sold Off Hard Since The Russia-Ukraine War Began
March 11, 2022
The S&P 500 is having a rough start to 2022, down 11.27% year to date. Since Russia invaded Ukraine on Feb. 24, the S&P 500 has fallen an additional 0.78%. Following are...
Via
Benzinga
7 Stocks to Buy After Sentiment Slipped to Lows
February 17, 2022
With sentiment souring over inflation and other concerns, contrarians may have an opportunity to bank on certain stocks to buy like these.
Via
InvestorPlace
Did Going Public Give This Company Momentum? Stran & Company Closes First Acquisition; Adds Over $7 Million in Annualized Revenue
February 03, 2022
Photo by Catkin on Pixabay This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice. Some...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 2, 2022
March 02, 2022
Upgrades Barclays upgraded the previous rating for Equitrans Midstream Corp (NYSE:ETRN) from Underweight to Equal-Weight. Equitrans Midstream earned $0.07 in the fourth...
Via
Benzinga
< Previous
1
2
...
10
11
12
13
14
15
16
17
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.